表紙:世界の動物用医薬品市場:市場機会と戦略(~2030年) - 新型コロナウイルス感染症(COVID-19)の影響と回復過程
市場調査レポート
商品コード
1025598

世界の動物用医薬品市場:市場機会と戦略(~2030年) - 新型コロナウイルス感染症(COVID-19)の影響と回復過程

Veterinary Pharmaceuticals Global Market Opportunities And Strategies To 2030: COVID-19 Impact And Recovery

出版日: | 発行: The Business Research Company | ページ情報: 英文 397 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.68円
世界の動物用医薬品市場:市場機会と戦略(~2030年) - 新型コロナウイルス感染症(COVID-19)の影響と回復過程
出版日: 2021年08月30日
発行: The Business Research Company
ページ情報: 英文 397 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の動物用医薬品市場を調査し、市場の概要、セグメント・地域別の市場規模の推移と予測、新型コロナウイルス感染症(COVID-19)の市場への影響、市場成長の推進要因および阻害要因の分析、主要地域の詳細動向、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 目次

第3章 図一覧

第4章 表一覧

第5章 レポート構造

第6章 イントロダクション

  • 市場区分:地域別
  • 市場区分:医薬品タイプ別
  • 市場区分:動物タイプ別
  • 市場区分:投与経路別
  • 市場区分:エンドユーザー別
  • 市場区分:ワクチンタイプ別
  • 市場区分:抗生物質別

第7章 動物用医薬品市場の特徴

  • 市場定義
  • 製品別
    • 動物用ワクチン
    • 動物用抗生物質
    • 動物用寄生虫駆除剤
    • その他
  • エンドユーザー別
    • 動物病院
    • 動物診療所
    • 薬局・ドラッグストア
  • 投与経路別
    • 経口
    • その他
  • 動物タイプ別
    • 家畜
    • コンパニオンアニマル
  • ワクチンタイプ別
    • 不活化ワクチン
    • 弱毒化ワクチン
    • 組換えワクチン
    • その他
  • 抗生物質別
    • テトラサイクリン
    • ペニシリン
    • スルホンアミド
    • マクロライド
    • アミノグリコシド
    • その他

第8章 サプライチェーン分析

  • 原材料サプライヤー
  • 受託調査機関(CRO)
  • 動物用医薬品メーカー
    • 創薬
    • 前臨床および臨床試験
    • 発見と承認時の特許
    • 医薬品製造
  • 受託製造機関(CMO)
  • 卸売業者/販売業者
  • 小売業者(薬局および獣医店)および獣医クリニック
  • 獣医師
  • 利用者

第9章 動物用医薬品市場:製品・サービス分析 - 製品・サービスの例

第10章 動物用医薬品市場の顧客情報

  • COVID-19による動物病院での治療の遅れ
  • COVID-19が動物病院に与える影響
  • 慢性疾患管理のための獣医学的遠隔医療
  • ペットの健康に対する寄生虫の影響
  • 獣医の臨床活動の減少
  • ミレニアル世代は自分の健康よりもペットの健康を優先する
  • 犬や猫を飼っている人は、ペットの治療費を心配している
  • 食用動物の生産者における抗生物質の適切な使用に関する意識の欠如
  • オピオイドが不足しているため、獣医師は効果の低い薬を治療の選択肢として使わざるを得ない
  • 米国の獣医師は、犬のマリファナ治療について語りたがらない
  • 米国のペット飼育率は過去数年で3倍に増加
  • 米国ではペット保険の普及率が非常に低い
  • 犬猫用の医薬品はまだ主に動物病院で販売されている
  • ペットの肥満は依然として大きな問題である
  • ペットオーナーは、人と動物の絆の効果に関する科学的研究を知れば知るほど、ペットの健康増進のために行動を起こす可能性が高くなる

第11章 動物用医薬品市場の動向と戦略

  • イノベーションを推進するための戦略的コラボレーションとパートナーシップ
  • チュアブル錠の開発
  • 動物愛護のためのジェネリック医薬品の製造
  • 抗生物質耐性に取り組むための獣医学におけるナノテクノロジーの応用
  • 猫の高血圧の治療のための経口薬液
  • サブユニットおよびウイルス様粒子(VLP)ベースのワクチンの使用
  • 免疫療法の使用
  • スーパーコンボ寄生虫駆除剤
  • ワクチンの開発
  • 関節炎の新しい治療法
  • 次世代シーケンス(NGS)の使用

第12章 世界の動物用医薬品市場の規制状況

  • 動物用医薬品業界向けの個別の規制の必要性
  • 現在の規制シナリオ
    • 米国
    • 欧州
    • インド
    • ブラジル
    • オーストラリア・ニュージーランド
    • アフリカ
  • 規制における地域格差
    • 規制ガイダンスの欠如
    • 動物用医薬品開発プロセスのバリエーション
    • 動物用医薬品の安全性に関する考慮事項のバリエーション
    • 登録手続きの違い
  • 世界の規制調和イニシアチブ
  • 動物用医薬品規制に関する最近の更新

第13章 新型コロナウイルス感染症(COVID-19)が市場に与える影響

  • 供給サイド
    • 世界を牽引する動物用製薬企業への影響
    • 新製品の発売の減少
    • 動物用医薬品メーカーが従う安全対策
    • イベント、会議、博覧会の取り消し
  • 需要サイド
    • 動物用医薬品の備蓄(パニック購入)
    • 動物用医薬品のオンライン購入
    • ペットの所有権と養子縁組の増加
    • 獣医師が提供している救急サービスのみ
  • 規制介入
  • 今後の展望

第14章 世界の動物用医薬品市場:市場規模と成長

  • 市場規模
  • 市場成長(実績値)
    • 市場成長要因
    • 新興市場の成長
    • ペットの支出の増加
    • 病気の有病率の増加
    • 市場抑制要因
    • 獣医師の不足
  • 市場成長(予測値)
    • 市場成長要因
    • ペット保険の普及率の向上
    • 市場抑制要因

第15章 世界の動物用医薬品市場:セグメント別

  • 医薬品タイプ別(実績値・予測値)
    • 動物用寄生虫駆除剤
    • 動物用ワクチン
    • その他
    • 動物用抗生物質
  • 動物タイプ別(実績値・予測値)
    • 家畜
    • コンパニオンアニマル
  • 投与経路別(実績値・予測値)
    • 経口投与
  • エンドユーザー別(実績値・予測値)
    • 動物病院
    • 薬局・ドラッグストア
    • 動物診療所

第16章 世界の動物用医薬品市場:サブセグメント別

  • ワクチンタイプ別(実績値・予測値)
    • 弱毒生ワクチン
    • 不活化ワクチン
    • 組換えワクチン
    • その他
  • 抗生物質別(実績値・予測値)
    • その他
    • テトラサイクリン
    • ペニシリン
    • マクロロード
    • スルホンアミド
    • アミノグリコシド

第17章 動物用医薬品市場の分析:地域・国別

  • 市場規模:地域別(実績値・予測値)
  • 市場規模:国別(実績値・予測値)

第18章 アジア太平洋地域の動物用医薬品市場

  • 市場概要
  • 市場成長(実績値)
  • 市場成長(予測値)
  • 市場規模:医薬品タイプ別
  • 市場規模:動物タイプ別
  • 市場規模:エンドユーザー別
  • 市場規模:抗生物質別
  • 市場分析:国別
  • オーストラリア
  • 中国
  • インドネシア
  • インド
  • 日本
  • 韓国

第19章 西欧の動物用医薬品市場

  • 市場概要
  • 市場成長(実績値)
  • 市場成長(予測値)
  • 市場規模:医薬品タイプ別
  • 市場規模:動物タイプ別
  • 市場規模:エンドユーザー別
  • 市場規模:抗生物質別
  • 市場分析:国別
  • フランス
  • ドイツ
  • 英国

第20章 東欧の動物用医薬品市場

  • 市場概要
  • 市場成長(実績値)
  • 市場成長(予測値)
  • 市場規模:医薬品タイプ別
  • 市場規模:動物タイプ別
  • 市場規模:エンドユーザー別
  • 市場規模:抗生物質別
  • ロシア

第21章 北米の動物用医薬品市場

  • 市場概要
  • 市場成長(実績値)
  • 市場成長(予測値)
  • 市場規模:医薬品タイプ別
  • 市場規模:動物タイプ別
  • 市場規模:エンドユーザー別
  • 市場規模:抗生物質別
  • 米国

第22章 南米の動物用医薬品市場

  • 市場概要
  • 市場成長(実績値)
  • 市場成長(予測値)
  • 市場規模:医薬品タイプ別
  • 市場規模:動物タイプ別
  • 市場規模:エンドユーザー別
  • 市場規模:抗生物質別
  • ブラジル

第23章 中東の動物用医薬品市場

  • 市場概要
  • 市場成長(実績値)
  • 市場成長(予測値)
  • 市場規模:医薬品タイプ別
  • 市場規模:動物タイプ別
  • 市場規模:エンドユーザー別
  • 市場規模:抗生物質別

第24章 アフリカの動物用医薬品市場

  • 市場概要
  • 市場成長(実績値)
  • 市場成長(予測値)
  • 市場規模:医薬品タイプ別
  • 市場規模:動物タイプ別
  • 市場規模:エンドユーザー別
  • 市場規模:抗生物質別

第25章 競合情勢

  • 企業プロファイル
  • Zoetis Inc.
    • 企業概要
    • 製品・サービス
    • 事業戦略
    • 財務情報
  • Boehringer Ingelheim GmbH
  • Merck & Co., Inc.
  • Elanco Animal Health Incorporated
  • Ceva Sante Animale

第26章 主な合併・買収

第27章 市場の背景:動物医療市場

  • 動物医療市場の特徴
    • 市場の定義
    • 市場区分:医療タイプ
    • 市場規模:地域別(2020年)
    • 市場規模:地域別(実績値・予測値)

第28章 市場機会と戦略

第29章 結論・提言

第30章 付録

第31章 著作権と免責事項

目次
Product Code: o&s291

Veterinary Pharmaceuticals Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global veterinary pharmaceuticals market.

Reasons to Purchase:

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Where is the largest and fastest growing market for the veterinary pharmaceuticals market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global veterinary pharmaceuticals market opportunities and strategies to 2030 report from the Business Research Company answers all these questions and many more.

The report covers the following chapters:

Executive Summary - The executive summary section of the report gives a brief overview and summary of the report.

Report Structure - This section gives the structure of the report and the information covered in the various sections.

Introduction - The introduction section gives the segmentation of the veterinary pharmaceuticals market by geography, by type of product, by animal type, by route of administration and by end use channel.

Market Characteristics - The market characteristics section of the report defines and explains the veterinary pharmaceuticals market. This chapter includes different products covered in the report and basic definitions.

Supply Chain - The supply chain section of the report defines and explains the key players in the veterinary pharmaceuticals industry supply chain.

Product Analysis - The product analysis section of the report describes the leading products along with key features and differentiators for those products/services.

Customer Information - This chapters covers recent customer and service providers' trends/preferences in the global veterinary pharmaceuticals market.

Trends And Strategies - This chapter describes the major trends shaping the global veterinary pharmaceuticals market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.

Regulatory Landscape- The section briefs on the regulatory landscape of veterinary pharmaceuticals.

Impact Of COVID-19 - The section briefs on the impact of COVID-19 on the veterinary pharmaceuticals market.

Global Market Size And Growth - This section contains the global historic (2015-2020) and forecast (2020-2025, 2030) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast period.

Segmentation - This section contains the market values (2015-2025, 2030F) and analysis for different segments in the market.

Global Macro Comparison - The global veterinary pharmaceuticals market comparison with macro-economic factors gives the veterinary pharmaceuticals market size, percentage of GDP, and average veterinary pharmaceuticals market expenditure.

Regional Analysis - This section contains the historic (2015-2020) and forecast (2020-2025, 2030F) market value and growth, and market share comparison by region.

Regional Market Size and Growth - This section contains the region's market size (2020), historic (2015-2020) and forecast (2020-2025, 2030F) market value, and growth and market share comparison of major countries within the region. This report includes information on all the regions (Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa), and five countries (China, India, Japan, the USA and the UK).

Competitive Landscape - This section covers details on the competitive landscape of the global veterinary pharmaceuticals market, estimated market shares and company profiles of the leading players.

Key Mergers And Acquisitions - This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.

Market Background - This section describes the animal medicine market of which the veterinary pharmaceuticals market is a segment. This chapter includes the animal medicine market 2015-2025, 2030F values, and regional analyses for the animal medicine market.

Opportunities And Strategies - This section gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.

Conclusions And Recommendations - This section includes conclusions and recommendations based on findings of the research.

Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered: 1) By Type Of Pharamaceutical: Veterinary Parasiticides; Veterinary Vaccines; Veterinary Antibiotics; Other Veterinary Pharmaceuticals

2) By Animal Type: Livestock; Companion Animal

3) By Route Of Administration: Oral; Others

4) By End Use Channel: Veterinary Hospitals; Pharmacies and Drug stores; Veterinary Clinics

5) By Type Of Antibiotic: Tetracyclines; Penicillin; Macrolides; Sulphanomides; Aminoglycosides; Others

6) By Type Of Vaccine: Live Attenuated Vaccines; Inactivated Vaccines; Recombinant Vaccines; Others

Companies Mentioned: Zoetis Inc.; Boehringer Ingelheim GmbH; Merck & Co., Inc.; Elanco Animal Health Incorporated; Ceva Sante Animale

Countries: China; India; Japan; Australia; Indonesia; South Korea; USA; Brazil; France; Germany; UK; Russia

Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and ten years forecast.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Veterinary Pharmaceuticals Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction

  • 6.1. Segmentation By Geography
  • 6.2. Segmentation By Type Of Pharmaceuticals
  • 6.3. Segmentation By Animal Type
  • 6.4. Segmentation By Route Of Administration
  • 6.5. Segmentation By End Use Channel
  • 6.6. Segmentation By Type Of Vaccines
  • 6.7. Segmentation By Type Of Antibiotics

7. Veterinary Pharmaceuticals Market Characteristics

  • 7.1. Market Definition
  • 7.2. Market Segmentation By Type Of Product
    • 7.2.1. Veterinary Vaccines
    • 7.2.2. Veterinary Antibiotics
    • 7.2.3. Veterinary Parasiticides
    • 7.2.4. Other Veterinary Pharmaceuticals
  • 7.3. Market Segmentation By End Use Channel
    • 7.3.1. Veterinary Hospitals
    • 7.3.2. Veterinary Clinics
    • 7.3.3. Pharmacies And Drug Stores
  • 7.4. Market Segmentation By Route Of Administration
    • 7.4.1. Oral
    • 7.4.2. Others
  • 7.5. Market Segmentation By Type Of Animal
    • 7.5.1. Livestock
    • 7.5.2. Companion Animals
  • 7.6. Market Segmentation By Type Of Vaccine
    • 7.6.1. Inactivated Vaccines
    • 7.6.2. Attenuated Vaccines
    • 7.6.3. Recombinant Vaccines
    • 7.6.4. Others
  • 7.7. Market Segmentation By Type Of Antibiotics
    • 7.7.1. Tetracyclines
    • 7.7.2. Penicillin
    • 7.7.3. Sulphonamides
    • 7.7.4. Macrolides
    • 7.7.5. Aminoglycosides
    • 7.7.6. Others

8. Veterinary Pharmaceuticals Market, Supply Chain Analysis

  • 8.1. Raw Material Suppliers
  • 8.2. Contract Research Organization (CRO)
  • 8.3. Veterinary Pharmaceutical Manufacturer
    • 8.3.1. Drug Discovery
    • 8.3.2. Preclinical And Clinical Trials
    • 8.3.3. Patents Upon Discovery And Approval
    • 8.3.4. Drug Manufacturing
  • 8.4. Contract Manufacturing Organization (CMO)
  • 8.5. Wholesalers/Distributors
  • 8.6. Retailers (Pharmacies And Veterinary Shops) And Veterinary Clinics
  • 8.7. Veterinarians
  • 8.8. End-Users

9. Veterinary Pharmaceuticals Market, Product/Service Analysis -Product/Service Examples

10. Veterinary Pharmaceuticals Market Customer Information

  • 10.1. Delay In Veterinary Care Due To COVID-19
  • 10.2. Impact Of COVID-19 On Veterinary Hospitals
  • 10.3. Veterinary Telemedicine For Chronic Disease Management
  • 10.4. Impact Of Parasites On Pets Health
  • 10.5. Decrease In Veterinary Clinical Activities
  • 10.6. Millennials Would Put Pet's Health Before Their Own
  • 10.7. Dog And Cat Owners Alike Are Concerned About The Cost Of Medical Treatments For Their Pets
  • 10.8. Lack Of Awareness Among Food Animal Producers About The Proper Use Of Antibiotics
  • 10.9. Opioids Shortages Compel Veterinarians To Use Less Effective Drugs As Therapeutic Choices
  • 10.10. US Veterinarians Are Reluctant To Discuss The Therapeutic Use Of Marijuana In Dogs
  • 10.11. Pet Ownership In The USA Has Tripled Over The Past Few Years
  • 10.12. Pet Insurance Penetration In The USA Is Very Low
  • 10.13. Cat And Dog Medications Are Still Sold Mainly In Veterinary Clinics
  • 10.14. Pet Obesity Remains A Big Issue
  • 10.15. The More Pet Owners Learn About Scientific Research On The Benefits Of The Human-Animal Bond, The More Likely They Are To Take Actions To Improve Pet Health.

11. Veterinary Pharmaceuticals Market Trends And Strategies

  • 11.1. Strategic Collaborations And Partnerships To Drive Innovations
  • 11.2. Development Of Chewable Tablets
  • 11.3. Production Of Generic Drugs For Animal Care
  • 11.4. Application Of Nanotechnology In Veterinary Medicines To Tackle Antibiotic Resistance
  • 11.5. Oral Drug Solutions For The Treatment Of Feline Hypertension
  • 11.6. Use of Subunit And Virus-Like Particle (VLP)-Based Vaccines
  • 11.7. Use Of Immunotherapy
  • 11.8. Super-Combo Parasiticides
  • 11.9. Development Of Vaccines
  • 11.10. New Treatments For Arthritis
  • 11.11. Use Of Next Generation Sequencing (NGS)

12. Global Veterinary Pharmaceuticals Market Regulatory Landscape

  • 12.1. Need For Separate Regulation For The Veterinary Pharmaceuticals Industry
  • 12.2. Current Regulatory Scenario
    • 12.2.1. USA
    • 12.2.2. Europe
    • 12.2.3. India
    • 12.2.4. Brazil
    • 12.2.5. Australia and New Zealand
    • 12.2.6. Africa
  • 12.3. Regional Disparities In Regulations
    • 12.3.1. Lack Of Regulatory Guidance
    • 12.3.2. Variations In Veterinary Pharmaceuticals Development Processes
    • 12.3.3. Variations In Safety Considerations For Veterinary Pharmaceuticals
    • 12.3.4. Differences In Registration Procedures
  • 12.4. Global Regulation Harmonization Initiatives
  • 12.5. Recent Updates On Veterinary Pharmaceutical Regulations

13. COVID-19 Impact On The Veterinary Pharmaceuticals Market

  • 13.1. Supply Side Factors
    • 13.1.1. Impact On Leading Global Veterinary Pharmaceuticals Companies
    • 13.1.2. Decline In The Launch Of New Products
    • 13.1.3. Safety Measures Being Followed By Veterinary Pharmaceuticals Manufacturers
    • 13.1.4. Revocation Of Events, Conferences And Expos
  • 13.2. Demand Side Factors
    • 13.2.1. Stockpiling Of Veterinary Pharmaceuticals (Panic Purchasing)
    • 13.2.2. Online Purchasing Of Veterinary Pharmaceuticals
    • 13.2.3. Increase In Pet Ownership And Adoptions
    • 13.2.4. Only Emergency Services Being Offered By Veterinarians
  • 13.3. Regulatory Interventions
  • 13.4. Future Outlook

14. Global Veterinary Pharmaceuticals Market Size And Growth

  • 14.1. Market Size
  • 14.2. Historic Market Growth, 2015 - 2020, Value ($ Million)
    • 14.2.1. Drivers Of The Market 2015 - 2020
    • 14.2.2. Emerging Markets Growth
    • 14.2.3. Increased Pet Spending
    • 14.2.4. Increased Disease Prevalence
    • 14.2.5. Restraints On The Market 2015 - 2020
    • 14.2.6. Shortages Of Veterinarians
  • 14.3. Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
    • 14.3.1. Drivers Of The Market 2020 - 2025
    • 14.3.2. Increasing Penetration Of Pet Insurance
    • 14.3.3. Restraints On The Market 2020 - 2025

15. Global Veterinary Pharmaceuticals Market Segmentation

  • 15.1. Global Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
    • 15.1.1. Veterinary Parasiticides
    • 15.1.2. Veterinary Vaccines
    • 15.1.3. Others-Veterinary Pharmaceuticals
    • 15.1.4. Veterinary Antibiotics
  • 15.2. Global Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
    • 15.2.1. Livestock
    • 15.2.2. Companion Animal
  • 15.3. Global Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
    • 15.3.1. Oral
  • 15.4. Global Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
    • 15.4.1. Veterinary Hospitals
    • 15.4.2. Pharmacies And Drug stores
    • 15.4.3. Veterinary Clinics

16. Global Veterinary Pharmaceuticals Market Sub-Segmentation

  • 16.1. Global Veterinary Vaccines Market, Segmentation By Type Of Vaccine, Historic And Forecast, 2015-2020, 2025F, 2030F, Value ($ Million)
    • 16.1.1. Live Attenuated Vaccines
    • 16.1.2. Inactivated Vaccines
    • 16.1.3. Recombinant Vaccines
    • 16.1.4. Others
  • 16.2. Global Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2020, 2025F, 2030F, Value ($ Million)
    • 16.2.1. Others
    • 16.2.2. Tetracyclines
    • 16.2.3. Penicillins
    • 16.2.4. Macrolodes
    • 16.2.5. Sulphonamides
    • 16.2.6. Aminoglycosides

17. Veterinary Pharmaceuticals Market, Regional And Country Analysis

  • 17.1. Global Veterinary Pharmaceuticals Market, By Region, Historic and Forecast, 2015-2020, 2025F, 2030F, Value ($ Million)
  • 17.2. Global Veterinary Pharmaceuticals Market, By Country, Historic and Forecast, 2015-2020, 2025F, 2030F, Value ($ Million)

18. Asia-Pacific Veterinary Pharmaceuticals Market

  • 18.1. Asia-Pacific Veterinary Pharmaceuticals Market Overview
    • 18.1.1. Region Information
    • 18.1.2. Market Information
    • 18.1.3. COVID-19 Impact
    • 18.1.4. Background Information
    • 18.1.5. Government Initiatives
    • 18.1.6. Regulations
    • 18.1.7. Regulatory Bodies
    • 18.1.8. Major Associations
    • 18.1.9. Tax Levied
    • 18.1.10. Corporate Tax Structure
    • 18.1.11. Investments
    • 18.1.12. Major Companies
  • 18.2. Asia-Pacific Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 18.3. Asia-Pacific Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 18.4. Asia-Pacific Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 18.5. Asia-Pacific Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 18.6. Asia-Pacific Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 18.7. Asia-Pacific Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 18.8. Asia-Pacific Veterinary Pharmaceuticals Market: Country Analysis
  • 18.9. Australia Veterinary Pharmaceuticals Market
  • 18.10. Australia Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 18.11. Australia Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 18.12. Australia Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 18.13. Australia Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 18.14. Australia Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 18.15. Australia Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 18.16. China Veterinary Pharmaceuticals Market
  • 18.17. China Veterinary Pharmaceuticals Market Overview
    • 18.17.1. Country Information
    • 18.17.2. Market Information
    • 18.17.3. COVID-19 Impact
    • 18.17.4. Background Information
    • 18.17.5. Government Initiatives
    • 18.17.6. Regulations
    • 18.17.7. Regulatory Bodies
    • 18.17.8. Corporate Tax Structure
    • 18.17.9. Associations
    • 18.17.10. Tax Levied
    • 18.17.11. Investments
    • 18.17.12. Major Companies
  • 18.18. China Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 18.19. China Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 18.20. China Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 18.21. China Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 18.22. China Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 18.23. China Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 18.24. Indonesia Veterinary Pharmaceuticals Market
  • 18.25. Indonesia Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 18.26. Indonesia Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 18.27. Indonesia Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 18.28. Indonesia Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 18.29. Indonesia Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 18.30. Indonesia Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 18.31. India Veterinary Pharmaceuticals Market
  • 18.32. India Veterinary Pharmaceuticals Market Overview
    • 18.32.1. Country Information
    • 18.32.2. Market Information
    • 18.32.3. COVID-19 Impact
    • 18.32.4. Background Information
    • 18.32.5. Government Initiatives
    • 18.32.6. Regulations
    • 18.32.7. Regulatory Bodies
    • 18.32.8. Major Associations
    • 18.32.9. Tax Levied
    • 18.32.10. Corporate Tax Structure
    • 18.32.11. Investments
    • 18.32.12. Major Companies
  • 18.33. India Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 18.34. India Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 18.35. India Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 18.36. India Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 18.37. India Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 18.38. India Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 18.39. Japan Veterinary Pharmaceuticals Market
  • 18.40. Japan Veterinary Pharmaceuticals Market Overview
    • 18.40.1. Country Information
    • 18.40.2. Market Information
    • 18.40.3. COVID-19 Impact
    • 18.40.4. Background Information
    • 18.40.5. Regulations
    • 18.40.6. Regulatory Bodies
    • 18.40.7. Major Associations
    • 18.40.8. Tax Levied
    • 18.40.9. Corporate Tax Structure
    • 18.40.10. Investments
    • 18.40.11. Major Companies
  • 18.41. Japan Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 18.42. Japan Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 18.43. Japan Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 18.44. Japan Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 18.45. Japan Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 18.46. Japan Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 18.47. South Korea Veterinary Pharmaceuticals Market
  • 18.48. South Korea Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 18.49. South Korea Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 18.50. South Korea Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 18.51. South Korea Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 18.52. South Korea Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 18.53. South Korea Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

19. Western Europe Veterinary Pharmaceuticals Market

  • 19.1. Western Europe Veterinary Pharmaceuticals Market Overview
    • 19.1.1. Region Information
    • 19.1.2. Market Information
    • 19.1.3. COVID-19 Impact
    • 19.1.4. Background Information
    • 19.1.5. Government Initiatives
    • 19.1.6. Regulations
    • 19.1.7. Regulatory Bodies
    • 19.1.8. Major Associations
    • 19.1.9. Corporate Tax Structure
    • 19.1.10. Investments
    • 19.1.11. Major Companies
  • 19.2. Western Europe Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 19.3. Western Europe Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 19.4. Western Europe Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 19.5. Western Europe Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 19.6. Western Europe Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 19.7. Western Europe Veterinary Pharmaceuticals Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 19.8. Western Europe Veterinary Pharmaceuticals Market: Country Analysis
  • 19.9. France Veterinary Pharmaceuticals Market
  • 19.10. France Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 19.11. France Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 19.12. France Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 19.13. France Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 19.14. France Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 19.15. France Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 19.16. Germany Veterinary Pharmaceuticals Market
  • 19.17. Germany Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 19.18. Germany Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 19.19. Germany Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 19.20. Germany Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 19.21. Germany Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 19.22. Germany Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 19.23. UK Veterinary Pharmaceuticals Market
  • 19.24. UK Veterinary Pharmaceuticals Market Overview
    • 19.24.1. Country Information
    • 19.24.2. Market Information
    • 19.24.3. COVID-19 Impact
    • 19.24.4. Background Information
    • 19.24.5. Government Initiatives
    • 19.24.6. Regulations
    • 19.24.7. Regulatory Bodies
    • 19.24.8. Major Associations
    • 19.24.9. Corporate Tax Structure
    • 19.24.10. Investments
    • 19.24.11. Major Companies
  • 19.25. UK Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 19.26. UK Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 19.27. UK Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 19.28. UK Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 19.29. UK Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 19.30. UK Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

20. Eastern Europe Veterinary Pharmaceuticals Market

  • 20.1. Eastern Europe Veterinary Pharmaceuticals Market Overview
    • 20.1.1. Region Information
    • 20.1.2. Market Information
    • 20.1.3. COVID-19 Impact
    • 20.1.4. Background Information
    • 20.1.5. Government Initiatives
    • 20.1.6. Regulations
    • 20.1.7. Regulatory Bodies
    • 20.1.8. Major Associations
    • 20.1.9. Tax Levied
    • 20.1.10. Corporate Tax Structure
    • 20.1.11. Investments
    • 20.1.12. Major Companies
  • 20.2. Eastern Europe Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 20.3. Eastern Europe Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 20.4. Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 20.5. Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 20.6. Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 20.7. Eastern Europe Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 20.8. Russia Veterinary Pharmaceuticals Market
  • 20.9. Russia Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 20.10. Russia Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 20.11. Russia Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 20.12. Russia Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 20.13. Russia Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 20.14. Russia Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

21. North America Veterinary Pharmaceuticals Market

  • 21.1. North America Veterinary Pharmaceuticals Market Overview
    • 21.1.1. Region Information
    • 21.1.2. Market Information
    • 21.1.3. COVID-19 Impact
    • 21.1.4. Background Information
    • 21.1.5. Government Initiatives
    • 21.1.6. Regulations
    • 21.1.7. Regulatory Bodies
    • 21.1.8. Major Associations
    • 21.1.9. Tax Levied
    • 21.1.10. Corporate Tax Structure
    • 21.1.11. Major Investments
    • 21.1.12. Major Companies
  • 21.2. North America Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 21.3. North America Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 21.4. North America Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 21.5. North America Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 21.6. North America Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 21.7. North America Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 21.8. USA Veterinary Pharmaceuticals Market
  • 21.9. USA Veterinary Pharmaceuticals Market Overview
    • 21.9.1. Country Information
    • 21.9.2. Market Information
    • 21.9.3. COVID-19 Impact
    • 21.9.4. Background Information
    • 21.9.5. Government Initiatives
    • 21.9.6. Regulatory Bodies
    • 21.9.7. Regulations
    • 21.9.8. Major Associations
    • 21.9.9. Tax Levied
    • 21.9.10. Corporate Tax Structure
    • 21.9.11. Major Investments
    • 21.9.12. Major Companies
  • 21.10. USA Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 21.11. USA Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 21.12. USA Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 21.13. USA Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 21.14. USA Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 21.15. USA Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

22. South America Veterinary Pharmaceuticals Market

  • 22.1. South America Veterinary Pharmaceuticals Market Overview
    • 22.1.1. Region Information
    • 22.1.2. Market Information
    • 22.1.3. COVID-19 Impact
    • 22.1.4. Background Information
    • 22.1.5. Government Initiatives
    • 22.1.6. Regulations
    • 22.1.7. Regulatory Bodies
    • 22.1.8. Major Associations
    • 22.1.9. Tax Levied
    • 22.1.10. Corporate Tax Structure
    • 22.1.11. Major Investments
    • 22.1.12. Major Companies
  • 22.2. South America Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 22.3. South America Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 22.4. South America Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 22.5. South America Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 22.6. South America Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 22.7. South America Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 22.8. Brazil Veterinary Pharmaceuticals Market
  • 22.9. Brazil Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 22.10. Brazil Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 22.11. Brazil Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 22.12. Brazil Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 22.13. Brazil Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 22.14. Brazil Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

23. Middle East Veterinary Pharmaceuticals Market

  • 23.1. Middle East Veterinary Pharmaceuticals Market Overview
    • 23.1.1. Region Information
    • 23.1.2. Market Information
    • 23.1.3. COVID-19 Impact
    • 23.1.4. Background Information
    • 23.1.5. Government Initiatives
    • 23.1.6. Regulatory Bodies
    • 23.1.7. Regulations
    • 23.1.8. Taxes Levied
    • 23.1.9. Corporate Tax Structure
    • 23.1.10. Associations
    • 23.1.11. Investments
    • 23.1.12. Major Companies
  • 23.2. Middle East Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 23.3. Middle East Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 23.4. Middle East Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 23.5. Middle East Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 23.6. Middle East Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 23.7. Middle East Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

24. Africa Veterinary Pharmaceuticals Market

  • 24.1. Africa Veterinary Pharmaceuticals Market Overview
    • 24.1.1. Region Information
    • 24.1.2. Market Information
    • 24.1.3. COVID-19 Impact
    • 24.1.4. Background Information
    • 24.1.5. Regulatory Bodies
    • 24.1.6. Government Initiatives
    • 24.1.7. Regulations
    • 24.1.8. Corporate Tax Structure
    • 24.1.9. Associations
    • 24.1.10. Taxes Levied
    • 24.1.11. Investments
    • 24.1.12. Major Companies
  • 24.2. Africa Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 24.3. Africa Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 24.4. Africa Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 24.5. Africa Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 24.6. Africa Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 24.7. Africa Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

25. Global Veterinary Pharmaceuticals Market Competitive Landscape

  • 25.1. Company Profiles
  • 25.2. Zoetis Inc.
    • 25.2.1. Company Overview
    • 25.2.2. Products And Services
    • 25.2.3. Business Strategy
    • 25.2.4. Financial Overview
  • 25.3. Boehringer Ingelheim GmbH
    • 25.3.1. Company Overview
    • 25.3.2. Products And Services
    • 25.3.3. Business Strategy
    • 25.3.4. Financial Overview
  • 25.4. Merck & Co., Inc.
    • 25.4.1. Company Overview
    • 25.4.2. Products And Services
    • 25.4.3. Business Strategy
    • 25.4.4. Financial Overview
  • 25.5. Elanco Animal Health Incorporated
    • 25.5.1. Company Overview
    • 25.5.2. Products And Services
    • 25.5.3. Business Strategy
    • 25.5.4. Financial Overview
  • 25.6. Ceva Sante Animale
    • 25.6.1. Company Overview
    • 25.6.2. Products And Services
    • 25.6.3. Business Strategy
    • 25.6.4. Financial overview

26. Key Mergers And Acquisitions In The Veterinary Pharmaceuticals Market

  • 26.1. Vibrac Acquired Assets Of Elanco Animal Health Inc.
  • 26.2. Vetoquinol Acquired Australian Assets Of Elanco Animal Health Inc.
  • 26.3. Elanco Animal Health Acquired Bayer Animal Health
  • 26.4. MSD Animal Health Acquired Worldwide Rights of VECOXAN from Elanco Health
  • 26.5. Boehringer Ingelheim Acquired Global Stem cell Technology
  • 26.6. Merck & Co. Inc. Announced The Acquisition Of Virbac's Anti-Parasitic Portfolio
  • 26.7. The Carlyle Group Acquired SeQuent Scientific Ltd.
  • 26.8. Friulchem Acquired Pharmabbie
  • 26.9. Manna Pro Acquired Promika, LLC Pet Brands
  • 26.10. Ceva Sante Animale Acquired Assets Of IDT Biologika GmbH
  • 26.11. Elanco Animal Health Acquired Aratana Therapeutics
  • 26.12. Henry Schein Animal Health Merges With Vets First Choice
  • 26.13. PHARMAQ Collaborated With Vinh Hoan
  • 26.14. Animal Health Division Of Merck & Co. Collaborated With Vinovo
  • 26.15. Wageningen Bioveterinary Research Collaborated With Ceva
  • 26.16. Animalcare Group Acquired Ecuphar
  • 26.17. Merck Animal Health Acquired Vallee S.A.
  • 26.18. Elanco Animal Health Acquired Boehringer Ingelheim Vetmedica's Vaccine Portfolio
  • 26.19. Ceva Acquired Portfolio Of Merial Swine And Cattle Vaccines
  • 26.20. Dechra Holdings US (A U.S Subsidiary of Dechra Pharmaceuticals PLC) Acquired Putney Inc.
  • 26.21. Zydus Cadila Acquired Zoetis
  • 26.22. Eli Lilly And Company Acquired Novartis Animal Health

27. Market Background: Animal Medicine Market

  • 27.1. Animal Medicine Market Characteristics
    • 27.1.1. Market Definition
    • 27.1.2. Segmentation Type Of Medicine
  • 27.2. Global Animal Medicine Market, Segmentation By Type Of Medicine, 2015 - 2025, Value ($ Billion)
  • 27.3. Global Animal Medicine Market, 2020, By Region, Value ($ Billion)
  • 27.4. Global Animal Medicine Market, 2015 - 2025, Historic And Forecast, By Region

28. Global Veterinary Pharmaceuticals Market Opportunities And Strategies

  • 28.1. Global Veterinary Pharmaceuticals Market In 2025 - Countries Offering Most New Opportunities
  • 28.2. Global Veterinary Pharmaceuticals Market In 2025 - Segments Offering Most New Opportunities
  • 28.3. Global Veterinary Pharmaceuticals Market In 2025 - Growth Strategies
    • 28.3.1. Market Trend Based Strategies
    • 28.3.2. Competitor Strategies

29. Veterinary Pharmaceuticals Market, Conclusions And Recommendations

  • 29.1. Conclusions
  • 29.2. Recommendations
    • 29.2.1. Product
    • 29.2.2. Place
    • 29.2.3. Price
    • 29.2.4. Promotion
    • 29.2.5. People

30. Appendix

  • 30.1. Market Data Sources
  • 30.2. Research Methodology
  • 30.3. Currencies
  • 30.4. Research Inquiries
  • 30.5. The Business Research Company

31. Copyright and Disclaimer